Press releases

Month Year

Email alerts

Apr 24, 2013

Medtronic Elects Scott C. Donnelly to the Board of Directors

MINNEAPOLIS - April 24, 2013 - Medtronic, Inc. (NYSE: MDT) today announced that its Board of Directors unanimously elected Scott C. Donnelly, chairman and CEO of Textron, Inc., a multi-industry...
Apr 24, 2013

The New England Journal of Medicine: Medtronic Biventricular Pacing Delivers Better Patient Outcomes for Those with AV Block and Reduced Pumping Function

MINNEAPOLIS - April 24, 2013 - Biventricular (BiV) pacing with Medtronic, Inc. (NYSE: MDT) cardiac resynchronization therapy (CRT) devices may offer a significant clinical advantage and improved...
Apr 15, 2013

American College of Cardiology Journal Publishes Outcomes of Diabetes Patients Treated with Medtronic's Resolute Stent

Implanted Medical Device for Coronary Artery Disease Performed As Well In Study Subjects With Diabetes Who Were Not Taking Insulin As In Those Without Diabetes

MINNEAPOLIS -- April 15, 2013 -- The current issue of JACC: Cardiovascular Interventions, a peer-reviewed journal published by the American College of Cardiology, includes an article that...
Apr 11, 2013

Medtronic Initiates U.S. Trial to Evaluate the Use of Subcutaneous Peripheral Nerve Stimulation for Chronic Back Pain

MINNEAPOLIS - April 11, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the first patient enrollments in the SubQStim II pivotal clinical trial to pursue U.S. Food and Drug Administration (FDA)...
Apr 9, 2013

Medtronic's Endurant 'AAA' Stent Graft Shows Sustained Durability in Complex Patients

Analysis of ENGAGE Registry Found Similarly Strong Outcomes with Device for Endovascular Treatment of Abdominal Aortic Aneurysms in Short and Standard Neck Lengths

MINNEAPOLIS -- April 9, 2013 -- Presented to endovascular specialists at the 35th Charing Cross International Symposium in London, a new analysis of clinical data on the Endurant AAA Stent Graft...

Show per page